Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cloud-Based Systems Becoming Key Pillar in eHealth Strategy

By LabMedica International staff writers
Posted on 28 Jun 2015
Cloud-based laboratory information management systems (LIMS) are becoming a key pillar in Europe’s e-Health strategy as data-management solutions for modern testing will generate more demand for these systems.

Investments in cloud-based LIMS are part of Europe’s e-Health strategy. More...
New analysis from Frost & Sullivan (Mountain View, CA, USA), in their report “Analysis of the Western European Laboratory Information Management System Market,” finds that the market earned revenues of USD 303.5 million in 2014 and estimates this to reach USD 394.1 million in 2021. Even as LIMS providers in Western Europe focus on offering hosted software-as-a-service with free automatic upgrades and built-in customizations, their success will depend on the ability of the products to meet the needs of diagnostic, specialty, and hospital laboratories to provide low turnaround times for testing patient samples.

“The development of LIMS that support genetic and molecular testing requirements can speed up these processes and have a high impact on preventative medicine in Western Europe,” said Frost & Sullivan healthcare industry analyst Srinivas Sashidhar, “For the specialized process of genetic testing, however, traditional LIMS will have to undergo modifications to suit the workflow requirements of a genetic laboratory. The integration of such features with traditional LIMS is also necessary to respond to the unique needs of complex diagnostic sectors such as cytogenetics, human leukocyte antigen typing, and flow cytometry.”

Therefore, LIMS must evolve to have higher data storage capacity as well as the ability to detect genetic arrangements and access sample records that contain gene database information. This will make capabilities such as high-speed computing and processing, and sophisticated software for specimen tracking, quality assurance, and quality control documentation crucial for success.”

While all this can be achieved, justifying the return on investment after replacing old LIMS will be a challenge for vendors in Western Europe; especially in the case of expensive high-end enterprise LIMS modules. Another cause for concern is that very few laboratories, hospitals, and research institutions are organized in Europe—either their management teams are not technically sound or vendors have not managed to clearly express the LIMS cost break-up. “When it comes to mid-sized laboratories, it is easier for vendors to explain product technicalities, reduce the consulting hours for the analysis of laboratory infrastructure, and achieve installation and execution within the scheduled time,” observed Sashidhar, “In other cases though, a communication gap prevails between vendors and customers during the initial stages of discussion, preventing both sides from fixing the LIMS installation price.”

As such, the future lies in integrating LIMS with electronic laboratory notebooks so that data from laboratory instruments can be automatically transferred back and forth in real-time. Integrating LIMS with hospital information systems (HIS) is also an upcoming trend in Europe.

“Instead of each laboratory operating its own LIMS and having vendors maintain the systems individually, a remotely located LIMS hub can support all laboratory operations within the region,” added Sashidhar, “The hospital laboratories integrated with this chain will also establish Web-enabled electronic patient records. Overall, this Service Integrated Architecture model will be an easier and cost-effective method for laboratory management.”

Frost & Sullivan’s other related studies include: “Analysis of the US LIMS Market,” “Global Survey on Laboratory Information Management Systems,” and “Opportunities in Healthcare Cloud Market in the United States and Europe.” All reports included in subscriptions provide detailed market opportunities and industry trends evaluated.

Related Links:

Frost & Sullivan
Analysis of the Western European Laboratory Information Management System Market, report
Growth, Innovation, & Leadership event – GIL 2015: Silicon Valley



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.